Synthesis and characterization of new galanthamine derivatives comprising peptide moiety

Protein and Peptide Letters

Volumn 16, Issue 9, 2009, Pages 1024-1028

  Vezenkov, Lyubomir T ^a   Georgievaa, Maria G ^a,b   Danalev, Dantcho L ^a   Ivanov, Tchavdar B ^a   Ivanova, Galya I ^c  

^a UNIVERSITY OF CHEMICAL TECHNOLOGY AND METALLURGY   (Bulgaria)

^b Sopharma Pharmaceuticals   (Bulgaria)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

Author keywords

Alzheimer's disease; Galanthamine; N (3,4 dichlorophenyl) D,L Ala OH; Peptides

Indexed keywords

DIPEPTIDE; DRUG DERIVATIVE; GALANTAMINE; OLIGOPEPTIDE;

ARTICLE; SYNTHESIS;

DIPEPTIDES; GALANTAMINE; OLIGOPEPTIDES;

EID: 69549108027     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609789055412     Document Type: Article

References (14)

1. Mary, A.; Renko, D.Z.; Guillou, C.; Thal, C. Potent Acetylcholinesterase Inhibitors: Design, Synthesis and Structure-Activity Relationships of Bis-interacting Ligands in the Galanthamine series. Bioorg. Med. Chem., 1998, 6, 1835-1850.
2. Han, S.Y.; Sweeney, J.E.; Bachman, E.S.; Schweiger, E.J.; Forloni, G.; Coyle, J.T.; Davis, B.M.; Joullie, M.M. Chemical and pharmacological characterization of galanthamine, an acethylcholinesterase inhibitor and its derivatives. A potential application in Alzheimer's disease? Eur. J. Med. Chem., 1992, 27, 673-687.
3. Carroll, P.; Furst, G.T.; Han, S.Y.; Joullie, M.M. Spectroscopic studies of galanthamine and galanthamine methiodide. Bull. Soc. Chim. Fr., 1990, 127, 769-775.
4. Mary, A.; Renko, D.Z.; Guillou, C.; Thal, C. Selective NDemethylation of galanthamine to norgalanthamine via a non classical Polovinski reaction. Tetrahedron Lett., 1997, 38, 5151-5152.
5. Guillou, C.; Beunard, J.L.; Gras, E.; Thal, C. An Efficient total synthesis of (±) galanthamine. Angew. Chem., 2001, 113(24), 4881- 4882.
6. Bores, G.; Kosley, R. Galanthamine derivatives for the treatment of Alzheimer's disease. Drugs Future, 1996, 21(6), 621-635.
7. Guillou, C.; Mary, A.; Renko, D.Z.; Gras, E.; Thal, C. Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine- galanthaminium salts. Bioorg. Med. Chem. Lett., 2000, 10(7), 637-639.
8. Bodanszky, M.; Bodanszky A. The practice of peptide synthesis, Akademie-Verlag: Berlin, 1985.
9. Schwizer, R.; Iselin, B.; Rittel, W.; Sieber, P. Synthesen zyklischer Polypeptide. c-Tetraglycyl und c-Hexaglycyl. Über aktivierte Ester VII. Helv. Chim. Acta, 1956, 39(3), 872-883.
10. Bodanszky, M. The Peptides, Gross E., Meienhofer J.: New York, San Francisco, London, Academic Press, 1979.
11. Changalov, M.M.; Ivanova, G.D.; Rangelov, M.A.; Acharia, P.; Acharia, S.; Minakawa, N.; Foldesi, A.; Stoineva, I.B.; Yomtova, V.M.; Roussev, C.D.; Matsuda, A.; Chattopadhyaya, J.; Petkov, D.D. 2 /3 -O-peptidyl Adenosine as a General Base Catalyst of its Own External Peptidyl Transfer: Implications for the Ribosome Catalytic Mechanism. ChemBioChem., 2005, 6(6), 992-996.
12. Robertson, S.A.; Ellman, J.A.; Shultz, P.G. A general and efficient route for chemical aminoacylation of transfer RNAs. J. Am. Chem. Soc., 1991, 113(7), 2722-2729.
13. Sanochemia Pharmzeutika, A.G. PCT Int. Appl. WO 0174820, Novel derivatives and analogues of galanthamine. 2001.
14. Sanochemia Pharmzeutika, A.G. PCT Int. Appl. WO 03080623, Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof, 2003.